Pulmonary Adenocarcinoma With Enteric Differentiation: Immunohistochemistry and Molecular Morphology

Autor: Fabrizio Tabbò, Antonio Santo, Sara Cingarlini, Eliana Gilioli, Licia Montagna, Marco Chilosi, Claudio Doglioni, Serena Pedron, Matteo Brunelli, Albino Eccher, Alessia Nottegar, Claudio Luchini, Emilio Bria, Nicola Veronese, Giorgio Inghirami, Maria Giulia Cangi, Chiara Ogliosi
Přispěvatelé: Nottegar, A., Tabbo, F., Luchini, C., Brunelli, M., Bria, E., Veronese, N., Santo, A., Cingarlini, S., Gilioli, E., Ogliosi, C., Eccher, A., Montagna, L., Pedron, S., Doglioni, C., Cangi, M. G., Inghirami, G., Chilosi, M., Tabbò, F., Cangi, M.G.
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Pathology
medicine.medical_specialty
Lung Neoplasms
Histology
intestinal-type adenocarcinoma
Cellular differentiation
DNA Mutational Analysis
Thyroid Nuclear Factor 1
Adenocarcinoma
Biology
medicine.disease_cause
Pathology and Forensic Medicine
Metastasis
Diagnosis
Differential

Proto-Oncogene Proteins p21(ras)
03 medical and health sciences
0302 clinical medicine
KRAS
Biomarkers
Tumor

medicine
Humans
CDX2 Transcription Factor
Pathology
Molecular

enteric
lung adenocarcinoma
intestinal-type adenocarcinoma
CDX-2
CDX2
KRAS

Lung
Keratin-7
enteric
Cancer
Cell Differentiation
Pulmonary adenocarcinoma with enteric differentiation (PAED)
lung adenocarcinoma
medicine.disease
CDX-2
Immunohistochemistry
Medical Laboratory Technology
030104 developmental biology
medicine.anatomical_structure
CDX2
Alveolar Epithelial Cells
030220 oncology & carcinogenesis
Mutation
Differential diagnosis
Colorectal Neoplasms
Zdroj: Europe PubMed Central
Popis: Pulmonary adenocarcinoma with enteric differentiation (PAED) is a rare subtype of lung adenocarcinoma recently recognized in the WHO classification. It is defined as an adenocarcinoma in which the enteric component exceeds 50% and have to show the expression of at least 1 immunohistochemical marker of enteric differentiation. Although the definition of this tumor type is very important, above all in the differential diagnosis between a primary lung tumor and a metastasis of colorectal adenocarcinoma, this cancer still lacks a distinctive immunohistochemical and molecular signature. We recruited the largest series in the literature of PAEDs according to the morphology and the positivity for intestinal markers. Then, we evaluated the immunohistochemical and molecular profile of these adenocarcinomas. In our series, CDX-2 and CK7 were the immunohistochemical markers mostly expressed by PAEDs. There was an inverse relationship between the expression of pnuemocytes markers, such as TTF-1, and intestinal markers. Molecular analysis revealed KRAS as the most frequently mutated gene (>60% of cases), with very few cases harboring abnormalities affecting EGFR, BRAF, and ALK genes. PAEDs are morphologically very heterogenous. The immunohistochemical profile based on CDX-2 and CK7 positivity of PAEDs appears very robust to support this diagnosis, and it is applicable also on small biopsies. KRAS appears as the most important mutated gene in such tumors. © 2016 Wolters Kluwer Health, Inc. All rights reserved.
Databáze: OpenAIRE